NICE rejects breast cancer drug for NHS funding
Decision now open to public consultation Related items fromOnMedica NICE rejects adjuvant use of breast cancer drug New breast cancer drug ‘unaffordable’ for NHS Cancer strategies failed to improve one-year survival Is crowdfunding for cancer patients paying for ‘quackery’? New cancer drug ‘refused’ by NICE
Source: OnMedica Latest News - Category: UK Health Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Funding | National Institute for Health and Clinical Excelle | UK Health